View Future GrowthLighthouse Gold 過去の業績過去 基準チェック /06Lighthouse Goldの収益は年平均-28.6%で減少しているが、Metals and Mining業界はdecliningで1.1%年平均の収益となった。主要情報-28.60%収益成長率-9.12%EPS成長率Metals and Mining 業界の成長29.18%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報28 Feb 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Jan 31Lighthouse Gold Inc. announced that it has received CAD 0.854 million in fundingOn January 29, 2026, Lighthouse Gold Inc. closed the transaction. The company issued 12,200,000 units at a price of CAD 0.07 per unit, for gross proceeds of CAD 854,000. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. All securities issued in connection with the Offering are subject to a statutory hold period of four months plus one day in accordance with Canadian securities legislation. A director of the Company participated in the Offeringお知らせ • Jan 15Lighthouse Gold Inc. announced that it expects to receive CAD 0.7 million in fundingLighthouse Gold Inc announced a non-brokered private placement to issue 10,000,000 units at a price of CAD 0.07 per unit for aggregate gross proceeds of CAD 700,000 on January 15, 2026. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. Completion of the Offering is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). Pursuant to applicable securities law, Securities issued under the Offering will be subject to a hold period which will expire four months and one day from the date of closing of the Offering. The Company anticipates to close the Offering on or about January 29, 2026.お知らせ • Jul 29Alerio Gold Corp., Annual General Meeting, Sep 24, 2025Alerio Gold Corp., Annual General Meeting, Sep 24, 2025.お知らせ • Jun 24Alerio Gold Corp. announced that it has received CAD 0.491 million in fundingOn June 23, 2025, Alerio Gold Corp. closed the transaction. The company announced that it has issued 24,550,000 Units at a price of CAD 0.02 per Unit for gross proceeds of CAD 491,000. Each Unit will consist of one common share and one-half of one Share purchase warrant. Each whole Warrant will entitle the holder thereof to acquire one additional Share at a price of CAD 0.05 per Share, for a period of 24 months from the closing date. In connection with the Offering, the Company paid an aggregate cash finder’s fee of CAD 9,920 to eligible arm’s length finders. Pursuant to applicable securities laws, all securities issued under the Private Placement are subject to a statutory hold period until October 24, 2025. The securities to be issued under the Debt Settlement Units and Convertible Notes will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.お知らせ • Jan 10+ 1 more updateAlerio Gold Corp. Announces Board ChangesAlerio Gold Corp. announced that its board of directors has appointed Ioannis Tsitos as a new director of the Company. Alerio also announced the resignation of Allan Fabbro as director. Mr. Rascan has over 30 years of capital markets experience and brings extensive expertise across institutional sales, brokerage, and executive leadership, having served as director for several publicly traded small-cap companies. Throughout his career, he has consistently driven value creation and championed innovation in emerging industries. As CEO of Liberty Leaf, Mr. Rascan led the company through Health Canada's rigorous licensing process, securing cultivation and processing licenses and achieving a market capitalization of +$100 million. In his role at Nova Mentis Life Science, he spearheaded initiatives, establishing Nova Mentis as the first company to secure orphan drug designation for psilocybin in both the United States and European Union for treating Fragile X Syndrome, a primary genetic cause of autism spectrum disorder (ASD) symptoms. His efforts enabled Canada's first approved Phase IIA clinical study to evaluate oral micro-dose psilocybin therapy for Fragile X Syndrome. Mr. Tsitos has over 35 years of experience in the mining industry, having spent 19 of those years with the BHP Billiton group. In his time in the industry, he has lived and worked in South Africa, Ecuador, Greece and United Kingdom, and has been working in Canada since 2000. Originally a physicist-geophysicist, he left BHP Billiton in 2008, where he had the title of New Business Manager for Minerals Exploration with a global reach, based in Vancouver. He has been instrumental in the identification, negotiation and execution of more than 50 exploration agreements over 11 different commodities with juniors, majors, as well as with state exploration and mining companies. Mr. Tsitos sits on several companies' boards as an Independent Director, has published articles in exploration and mining magazines on relevant topics and has been a strong advocate of anti-corruption policies in the mining industry. Until recently, he was the President of Goldsource Mines, which was sold in mid-2024 to the gold producer, Mako Mining. Mr. Tsitos has also been part of two discovery teams with BHP Billiton in porphyry-copper and nickel-sulphide deposits. He holds a B.Sc. degree in Physics from the University of Athens and a Master's degree in Applied Geophysics and Geology from the University of Birmingham, UK In addition, he has completed management and finance studies as part of an MBA program with Herriot Watt University, Edinburgh.Board Change • Oct 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Feb 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$355k free cash flow). Share price has been highly volatile over the past 3 months (254% average daily change). Revenue is less than US$1m. Market cap is less than US$10m (€1.05m market cap, or US$1.13m). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).Recent Insider Transactions • Dec 16Insider recently bought €83k worth of stockOn the 14th of December, Ray Van Empel bought around 2m shares on-market at roughly €0.041 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €87k more in shares than they have sold in the last 12 months.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Member of the Advisory Board Praveen Varshney was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Lighthouse Gold の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:3FR 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費28 Feb 260-11030 Nov 25000031 Aug 25000031 May 25000028 Feb 250-170030 Nov 240-160031 Aug 240-160031 May 240-171029 Feb 240-11030 Nov 230-11031 Aug 230-11031 May 230-11028 Feb 230-11030 Nov 220-11031 Aug 220-11030 Nov 210-110質の高い収益: 3FRは現在利益が出ていません。利益率の向上: 3FRは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 3FRは利益が出ておらず、過去 5 年間で損失は年間28.6%の割合で増加しています。成長の加速: 3FRの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 3FRは利益が出ていないため、過去 1 年間の収益成長をMetals and Mining業界 ( 18.5% ) と比較することは困難です。株主資本利益率高いROE: 3FRの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 16:46終値2026/05/22 00:00収益2026/02/28年間収益2025/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Lighthouse Gold Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jan 31Lighthouse Gold Inc. announced that it has received CAD 0.854 million in fundingOn January 29, 2026, Lighthouse Gold Inc. closed the transaction. The company issued 12,200,000 units at a price of CAD 0.07 per unit, for gross proceeds of CAD 854,000. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. All securities issued in connection with the Offering are subject to a statutory hold period of four months plus one day in accordance with Canadian securities legislation. A director of the Company participated in the Offering
お知らせ • Jan 15Lighthouse Gold Inc. announced that it expects to receive CAD 0.7 million in fundingLighthouse Gold Inc announced a non-brokered private placement to issue 10,000,000 units at a price of CAD 0.07 per unit for aggregate gross proceeds of CAD 700,000 on January 15, 2026. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. Completion of the Offering is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). Pursuant to applicable securities law, Securities issued under the Offering will be subject to a hold period which will expire four months and one day from the date of closing of the Offering. The Company anticipates to close the Offering on or about January 29, 2026.
お知らせ • Jul 29Alerio Gold Corp., Annual General Meeting, Sep 24, 2025Alerio Gold Corp., Annual General Meeting, Sep 24, 2025.
お知らせ • Jun 24Alerio Gold Corp. announced that it has received CAD 0.491 million in fundingOn June 23, 2025, Alerio Gold Corp. closed the transaction. The company announced that it has issued 24,550,000 Units at a price of CAD 0.02 per Unit for gross proceeds of CAD 491,000. Each Unit will consist of one common share and one-half of one Share purchase warrant. Each whole Warrant will entitle the holder thereof to acquire one additional Share at a price of CAD 0.05 per Share, for a period of 24 months from the closing date. In connection with the Offering, the Company paid an aggregate cash finder’s fee of CAD 9,920 to eligible arm’s length finders. Pursuant to applicable securities laws, all securities issued under the Private Placement are subject to a statutory hold period until October 24, 2025. The securities to be issued under the Debt Settlement Units and Convertible Notes will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.
お知らせ • Jan 10+ 1 more updateAlerio Gold Corp. Announces Board ChangesAlerio Gold Corp. announced that its board of directors has appointed Ioannis Tsitos as a new director of the Company. Alerio also announced the resignation of Allan Fabbro as director. Mr. Rascan has over 30 years of capital markets experience and brings extensive expertise across institutional sales, brokerage, and executive leadership, having served as director for several publicly traded small-cap companies. Throughout his career, he has consistently driven value creation and championed innovation in emerging industries. As CEO of Liberty Leaf, Mr. Rascan led the company through Health Canada's rigorous licensing process, securing cultivation and processing licenses and achieving a market capitalization of +$100 million. In his role at Nova Mentis Life Science, he spearheaded initiatives, establishing Nova Mentis as the first company to secure orphan drug designation for psilocybin in both the United States and European Union for treating Fragile X Syndrome, a primary genetic cause of autism spectrum disorder (ASD) symptoms. His efforts enabled Canada's first approved Phase IIA clinical study to evaluate oral micro-dose psilocybin therapy for Fragile X Syndrome. Mr. Tsitos has over 35 years of experience in the mining industry, having spent 19 of those years with the BHP Billiton group. In his time in the industry, he has lived and worked in South Africa, Ecuador, Greece and United Kingdom, and has been working in Canada since 2000. Originally a physicist-geophysicist, he left BHP Billiton in 2008, where he had the title of New Business Manager for Minerals Exploration with a global reach, based in Vancouver. He has been instrumental in the identification, negotiation and execution of more than 50 exploration agreements over 11 different commodities with juniors, majors, as well as with state exploration and mining companies. Mr. Tsitos sits on several companies' boards as an Independent Director, has published articles in exploration and mining magazines on relevant topics and has been a strong advocate of anti-corruption policies in the mining industry. Until recently, he was the President of Goldsource Mines, which was sold in mid-2024 to the gold producer, Mako Mining. Mr. Tsitos has also been part of two discovery teams with BHP Billiton in porphyry-copper and nickel-sulphide deposits. He holds a B.Sc. degree in Physics from the University of Athens and a Master's degree in Applied Geophysics and Geology from the University of Birmingham, UK In addition, he has completed management and finance studies as part of an MBA program with Herriot Watt University, Edinburgh.
Board Change • Oct 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Feb 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$355k free cash flow). Share price has been highly volatile over the past 3 months (254% average daily change). Revenue is less than US$1m. Market cap is less than US$10m (€1.05m market cap, or US$1.13m). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).
Recent Insider Transactions • Dec 16Insider recently bought €83k worth of stockOn the 14th of December, Ray Van Empel bought around 2m shares on-market at roughly €0.041 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €87k more in shares than they have sold in the last 12 months.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Member of the Advisory Board Praveen Varshney was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.